Business
Amylyx Pharmaceuticals to Present at the 24th Annual Needham Virtual Healthcare Conference
CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Amylyx Pharmaceuticals, Inc. (Nasdaq: AMLX) (“Amylyx” or the “Company”) today announced that management will present at
About this update from Amylyx Pharmaceuticals, Inc.
CAMBRIDGE, Mass. --(BUSINESS WIRE)-- Amylyx Pharmaceuticals, Inc. (Nasdaq: AMLX) (“Amylyx” or the “Company”) today announced that management will present at the 24th Annual Needham Virtual Healthcare Conference . The corporate presentation will take place on Wednesday, April 9, 2025 , at 8:00 a.m. ET . A live webcast of the presentation can be accessed under “Events and Presentations” in the Investor section of the Company’s website, https://investors.amylyx.com/events-presentations , and will be available for replay for 90 days following the event. About Amylyx Pharmaceuticals At Amylyx, our mission is to usher in a new era of treating diseases with high unmet needs. Where others see challenges, we see opportunities that we pursue with urgency, rigorous science, and unwavering commitment to the communities we serve. We are currently focused on three investigational therapies across several neurodegenerative and endocrine diseases in which we believe they can make the greatest impact. For more information, visit amylyx.com and follow us on LinkedIn and X . For investors, please visit investors.amylyx.com . View source version on businesswire.com : https://www.businesswire.com/news/home/20250402678227/en/ Media Amylyx Media Team +1 (857) 799-7274 [email protected] Investors Lindsey Allen Amylyx Pharmaceuticals, Inc. +1 (857) 320-6244 [email protected] Source: Amylyx Pharmaceuticals, Inc.
View stock analysis, news, and events for Amylyx Pharmaceuticals, Inc.